Unlock instant, AI-driven research and patent intelligence for your innovation.

FMT donor screening method based on PFOR enzyme activity guidance and application of FMT donor screening method

A screening method and enzyme activity technology, which is applied in the field of medical testing, can solve the problems of being unable to cultivate Clostridium difficile FMT donors and the harsh culture conditions of Clostridium difficile, so as to inhibit the growth of Clostridium difficile, and is suitable for widespread application and operation. convenient effect

Pending Publication Date: 2022-05-13
THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In the past, to explore the inhibitory effect of drugs on Clostridium difficile, the culture of Clostridium difficile was usually used to explore the inhibitory effect of drugs on Clostridium difficile. Screening of FMT donors by culturing Clostridium difficile

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • FMT donor screening method based on PFOR enzyme activity guidance and application of FMT donor screening method
  • FMT donor screening method based on PFOR enzyme activity guidance and application of FMT donor screening method
  • FMT donor screening method based on PFOR enzyme activity guidance and application of FMT donor screening method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] This example provides a PFOR enzyme activity-oriented screening method for FMT donors, targeting the PFOR enzyme in Clostridium difficile, and testing the inhibition rate of the fecal liquid provided by FMT donors to PFOR enzymes, screening prediction and / or evaluate the therapeutic effect of FMT on Clostridium difficile infection.

[0045] Its technical principle is as figure 1 As shown, the PFOR enzyme is involved in the pyruvate metabolism of Clostridium difficile, that is, PFOR (pyruvate ferredoxin oxidoreductase) catalyzes the oxidative decarboxylation of pyruvate to generate acetyl-CoA (acetyl-CoA) and CO 2 , Pyruvate decarboxylation reaction is the first step for Clostridium difficile to obtain energy through glycolysis, and inhibiting the activity of PFOR can effectively inhibit Clostridium difficile.

[0046] The specific steps of its screening method are as follows:

[0047] (1) cultivating Escherichia coli with PFOR enzyme plasmid;

[0048] (2) inducing E...

Embodiment 2

[0054] On the basis of the foregoing examples, the present embodiment further limits the culture method of cultivating Escherichia coli with the PFOR enzyme plasmid:

[0055] 1. Preparation of LB medium: liquid medium (broth): 5g LB powder dissolved in 500ml distilled water, solid medium (agar): 3.5gLB powder dissolved in 100mL distilled water. Place the prepared medium in a high-pressure steam sterilizer, and sterilize it under high pressure at 121°C for 15 minutes. The liquid volume in the culture bottle should not exceed 1 / 3 of the range of the bottle itself. Take the medium out of the high-temperature sterilizer at about 65°C , add ampicillin (100 μg / mL) before solidification of the solid medium and mix well, then pour the medium into petri dishes, and add about 10 mL of medium for each. Then let it cool and solidify. Add ampicillin to the liquid medium after it cools down. 2. Bacterial plate inoculation: Pick a single colony from the existing medium, streak the plate in...

Embodiment 3

[0057] In this embodiment, the E. coli with the PFOR enzyme plasmid cultivated above was induced and extracted with PFOR enzyme, specifically as follows:

[0058] 1. Take about 50mL of liquid culture medium (with ampicillin added) in a centrifuge tube, pick a single colony from the plate obtained by growing bacteria, put it in a centrifuge tube, and place it in a shaking incubator at 37°C, 220rpm, for about 200min. After shaking for about 200 minutes, add isopropyl-β-D-thiogalactoside (IPTG) for induction (final concentration of IPTG is 0.5mMol / ml), place in a shaking incubator, 25°C, 220rpm, 20h .

[0059] 2. Take 50ml of the induced bacteria solution, centrifuge at 12000g, 4°C, 5min, and remove the supernatant. Resuspend in an equal volume of pure water and centrifuge again to remove the supernatant. Then resuspend in 10mL pure water. Sonicate 10mL of bacterial solution on ice at 400W for 5s with an interval of 5s for about 10min. The obtained solution is the crude enzyme...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an FMT donor screening method based on PFOR enzyme activity guidance, which takes PFOR enzyme in clostridium difficile as a target spot, and screens, predicts and / or evaluates the treatment effect of FMT on clostridium difficile infection by testing the inhibition ratio of fecal bacteria liquid provided by the FMT donor to the PFOR enzyme. According to the application, PFOR enzyme in clostridium difficile is taken as a target spot, escherichia coli with PFOR enzyme plasmids is cultured, the escherichia coli is induced to generate the PFOR enzyme under the action of IPTG (isopropyl-beta-d-thiogalactoside), the PFOR enzyme inhibition ratio of fecal bacteria liquid provided by an FMT donor is detected through an in-vitro experiment, the therapeutic effect of FMT based on the donor on clostridium difficile infection can be preliminarily judged, the application can be used for screening FMT donors, and the application has the advantages that the application is wide in application range and high in practicability. According to the method provided by the invention, the FMT is used as a donor, or the quality of the provided excrement is evaluated, so that the complex process of directly culturing the clostridium difficile is avoided, the inhibition effect of the clostridium difficile liquid provided by the FMT donor on the clostridium difficile can be deduced through enzyme reaction, and the step of obtaining energy for the clostridium difficile by the PFOR enzyme has great significance on the clostridium difficile.

Description

technical field [0001] The invention relates to the technical field of medical detection, in particular to a method for screening FMT donors guided by PFOR enzyme activity and its application. Background technique [0002] Clostridium difficile (CD) is a spore-forming anaerobic Gram-positive bacterium found in the environment and gut of animals and humans. Clostridium difficile infection (CDI) is the long-term or irregular use of broad-spectrum antimicrobials, immunosuppressants, and radiotherapy and chemotherapy drugs, which leads to intestinal flora imbalance, Clostridium difficile proliferates and secretes toxins, leading to abdominal pain, diarrhea, etc. series of clinical symptoms. The treatment of CDI has been explored for a long time. At present, there are few treatment methods for Clostridium difficile. Antibacterial drugs are the primary means of infection treatment. non-dasimycin) has been routinely used in the treatment of CDI. However, there is currently no go...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/26C12Q1/18C12R1/145
CPCC12Q1/26C12Q1/18G01N2333/33G01N2333/90203
Inventor 梁思成肖丽君吕沐瀚阳泰钟晓琳齐晓怡邓明明
Owner THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIV